Inventor
DING ZHAOZHONG
CN13 patents
⚠️ This page may combine multiple inventors who share the name “DING ZHAOZHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
8 patentsUS9962388B2May 8, 2018
Pyrrolopyrimidine compounds used as TLR7 agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD14 citations83
US10555949B2Feb 11, 2020
Pyrrolopyrimidine compounds used as TLR7 agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2 citations72
US10947245B2Mar 16, 2021
Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activity
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US10676478B2Jun 9, 2020
7-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations51
US10683296B2Jun 16, 2020
TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US10442811B2Oct 15, 2019
Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US10780091B2Sep 22, 2020
TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations49
US10654856B2May 19, 2020
Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations49